Mesenchymal chondrosarcoma (Literature review)
Abstract
Mesenchymal chondrosarcoma is an extremely rare disease. A special kind of chondrosarcoma, quite sharply different in its clinical and x-ray morphological features from its other variants, and has definitely a different tactic of diagnosis and treatment.
About the Authors
A. V. Lazukin
Russian Scientific Center of Radiology of the Ministry of health of the Russian Federation
Russian Federation
Russian Federation
117997, GSP-7, Moscow, str. Trade Union, 86.
V. V. Teplyakov
Russian Scientific Center of Radiology of the Ministry of health of the Russian Federation
Russian Federation
Russian Federation
117997, GSP-7, Moscow, str. Trade Union, 86.
O. P. Blyzniukov
Russian Scientific Center of Radiology of the Ministry of health of the Russian Federation
Russian Federation
Russian Federation
117997, GSP-7, Moscow, str. Trade Union, 86.
V. D. Baryshnikovа
Russian Scientific Center of Radiology of the Ministry of health of the Russian Federation
Russian Federation
Russian Federation
117997, GSP-7, Moscow, str. Trade Union, 86.
N. I. Sergeev
Russian Scientific Center of Radiology of the Ministry of health of the Russian Federation
Russian Federation
Russian Federation
117997, GSP-7, Moscow, str. Trade Union, 86.
A. A. Shaposhnikov
Russian Scientific Center of Radiology of the Ministry of health of the Russian Federation
Russian Federation
Russian Federation
117997, GSP-7, Moscow, str. Trade Union, 86.
A. O. Akhov
Russian Scientific Center of Radiology of the Ministry of health of the Russian Federation
Russian Federation
Russian Federation
117997, GSP-7, Moscow, str. Trade Union, 86.
M. N. Demina
Russian Scientific Center of Radiology of the Ministry of health of the Russian Federation
Russian Federation
Russian Federation
117997, GSP-7, Moscow, str. Trade Union, 86.
References
1. Onkologiya: Spravochnik prakticheskogo vracha. Pod red. chl.-korr. RAMN prof. I.V. Poddubnoy. M., 2009:108 (In Russ.).
2. Fedenko AA, Bohyan BYu, Gorbunova VA, Mahson AN, Teplyakov VV. Prakticheskie rekomendacii po lecheniyu pervichnyh zlokachestvennyh opuholej kostej (osteosarkomy, sarkomy Yuinga). 2018;8(3/2):227-239 (In Russ.). https://rosoncoweb.ru/standarts/RUSSCO/2018/2018-16.pdf.
3. Matsko DE. Sarkomy kostey: klassifikatsiya, gistologich-eskoye stroyeniye, osobennosti morfologicheskoy diagnostiki. Prakticheskaya onkologiya. 2010;11(1):1-10 (In Russ.).
4. Личные архивы патоморфолога д.м.н., профессора Близнюкова О.П.
5. Aliyev MD, Solov'yev YuN, Kharatishvili TK, Musayev ER, Sokolovskiy VA. Khondrosarkoma kosti. M., 2006 (In Russ.).
6. Зацепин СТ. Руководство для врачей. Костная патология взрослых. М.: «Медицина». 2001 [Zatsepin ST. Rukovodstvo dlya vrachey. Kostnaya patologiya vzroslykh. M.: «Meditsina». 2001 (In Russ.)].
7. Jie Xu, Dasen Li, Lu Xie, Shun Tang, Wei Guo. Mesenchymal Chondrosarcoma of Bone and Soft Tissue: A Systematic Review of 107 Patients in the Past 20 Years. PLoS One. 2015;10(4):e0122216.
8. Kawaguchi S, Weiss I, Lin PP, Huh WW, Lewis VO. Radiation therapy is associated with fewer recurrences in mesenchymal chondrosarcoma. Clin Orthop Relat Res. 2014;472:856-864. DOI: 10.1007/s11999-013-3064-x.
9. Schneiderman BA, Kliethermes SA, Nystrom LM. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database. Clin Orthop Relat Res. 2017;475(3):799-805.
10. Cesari M, Bertoni F, Bacchini P et al. Mesenchymal chondrosarcoma: an analysis of patients treated at a single institution. Tumori. 2007;93(5):423-427.
11. Dickey ID, Rose PS, Fuchs B et al. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. J Bone Joint Surg Am. 2004;86-A:2412-2418.
12. Grimer RJ, Gosheger G, Taminiau A et al. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group. Eur J Cancer. 2007;43:2060-2065.
13. Boriani S, Bandiera S, Biagini R et al. Chordoma of the mobile spine: fifty years of experience. Spine. (Phila Pa 1976). 2006;31:493-503.
14. Cotterill SJ, Ahrens S, Paulussen M et al. Prognostic factors in Ewings tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewings Sarcoma Study Group. J Clin Oncol. 2000;18:3108-3114.
15. Paulussen M, Ahrens S, Craft AW et al. Ewings tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewings Sarcoma Studies patients. J Clin Oncol. 1998;16:3044-3052.
16. Pinkerton CR, Bataillard A, Guillo S et al. Treatment strategies for metastatic Ewings sarcoma. Eur J Cancer. 2001;37: 1338-1344.
17. Leavey PJ, Collier AB. Ewing sarcoma: prognostic criteria, outcomes and future treatment. Expert Rev Anticancer Ther. 2008;8:617-624.
18. Aurias A, Rimbaut C, Buffe D et al. Translocation involving chromosome 22 in Ewings sarcoma: a cytogenetic study of four fresh tumors. Cancer Genet Cytogenet. 1984;12:21-25.
19. Turc-Carel C, Philip I, Berger MP et al. Chromosome study of Ewings sarcoma (ES) cell lines. Consistency of a reciprocal translocation t(11;22)(q24;q12). translocation t(11;22) (q24;q12). Cancer Genet Cytogenet. 1984;12(1):1-19.
20. Zoubek A, Pfleiderer C, Salzer-Kuntschik M et al. Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data. Br J Cancer. 1994;70:908-913.
21. Sorensen PH, Lessnick SL, Lopez-Terrada D et al. A second Ewings sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet. 1994;6:146-151.
22. Machado I, Noguera R, Pellin A et al. Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR. Diagn Mol Pathol. 2009;18:189-199.
23. Cangir A, Vietti TJ, Gehan EA et al. Ewings sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewings sarcoma studies. Cancer. 1990;66:887-893.
24. Bernstein ML, Devidas M, Lafreniere D et al. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Childrens Cancer Group Phase II Study 9457-a report from the Childrens Oncology Group. J Clin Oncol. 2006;24:152-159.
25. Bacci G, Ferrari S, Bertoni F et al. Prognostic factors in nonmetastatic Ewings sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortope-dico Rizzoli. J Clin Oncol. 2000;18:4-11.
26. Mark D Murphey, Eric A Walker, Anthony J Wilson, Mark J Kransdorf, H Thomas Temple, Francis H Gannon. Imaging of Primary Chondrosarcoma: Radiologic-Pathologic Correlation. RadioGraphics. 2003;23:1245-1278.
27. Lichtenstein L, Bernstein D. Unusual benign and malignant chondroid tumors of bone. A survey of some mesenchymal cartilage tumors and malignant chondroblastic tumors, including a few multicentric ones, as well as many atypical benign chondroblastomas and chondromyxoid fibromas. Cancer. 1959;12:1142-1157.
28. Michael W Bishop, Jessica M Somerville, Armita Bahrami, Sue C Kaste, Rodrigo B Interiano, Jianrong Wu, Shenghua Mao, Frederick A Boop, Regan F Williams, Alberto S Pappo, Sandeep Samant. Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective Review. Sarcoma. 2015:608279.
29. Italiano A, Mir O, Cioffi A, Palmerini E, Piperno-Neumann S, Perrin C, Chaigneau L, Penel N, Duffaud F, Kurtz JE, Collard O, Bertucci F, Bompas E, Le Cesne A, Maki RG, Ray Coquard I, Blay JY. Advanced chondrosarcomas: role of chemotherapy and survival. Annals of Oncology. 2013;24(11):2916-2922.
30. Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am. 2009;91:1063-1072.
Review
For citations:
Lazukin A.V., Teplyakov V.V., Blyzniukov O.P., Baryshnikovа V.D., Sergeev N.I., Shaposhnikov A.A., Akhov A.O., Demina M.N. Mesenchymal chondrosarcoma (Literature review). Bone and soft tissue sarcomas, tumors of the skin. 2019;11(3):42-52. (In Russ.)
Views:
162
Email this article 
